Windsor, United Kingdom

Stephen R Tudhope


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen R Tudhope

Introduction

Stephen R Tudhope is a notable inventor based in Windsor, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of leukotriene antagonists. His work focuses on creating compounds that can aid in the treatment of various respiratory diseases.

Latest Patents

Stephen R Tudhope holds a patent for "Aryl alkenoic acid derivatives as leukotriene antagonists." This patent describes aryl alkenoic acid derivatives and their physiologically acceptable salts, which are recognized as potent leukotriene antagonists. These compounds are particularly useful in treating circulatory diseases, with a preference for respiratory conditions such as asthma. The derivatives are characterized by a general formula that includes specific structural components.

Career Highlights

Throughout his career, Tudhope has been associated with Miles Inc., where he has contributed to innovative research and development. His work has led to advancements in therapeutic options for patients suffering from respiratory ailments. With a focus on practical applications, his inventions aim to improve the quality of life for individuals with chronic conditions.

Collaborations

Stephen R Tudhope has collaborated with notable colleagues, including Trevor S Abram and Peter Norman. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medicinal chemistry.

Conclusion

In summary, Stephen R Tudhope is a distinguished inventor whose work in developing leukotriene antagonists has the potential to significantly impact the treatment of respiratory diseases. His contributions to the field exemplify the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…